Works by LAROSA, MONICA
Results: 13
Comparable efficacy with similarly low risk of hypoglycaemia in patient‐ vs physician‐managed basal insulin initiation and titration in insulin‐naïve type 2 diabetic subjects: The Italian Titration Approach Study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2020, v. 36, n. 6, p. 1, doi. 10.1002/dmrr.3304
- By:
- Publication type:
- Article
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effectiveness of switching from first-generation basal insulin to Glargine 300 U/mL in children and adolescents with type 1 diabetes: results from the ISPED CARD database.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 9, p. 1169, doi. 10.1007/s00592-024-02304-2
- By:
- Publication type:
- Article
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 10, p. 1317, doi. 10.1007/s00592-022-01925-9
- By:
- Publication type:
- Article
Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2003, v. 52, n. 6, p. 1047, doi. 10.1093/jac/dkg467
- By:
- Publication type:
- Article
Treatment intensification following glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE‐G real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3576, doi. 10.1111/dom.15697
- By:
- Publication type:
- Article
Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 327, doi. 10.1111/dom.14560
- By:
- Publication type:
- Article
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
- Published in:
- BMC Microbiology, 2008, v. 8, p. 1, doi. 10.1186/1471-2180-8-23
- By:
- Publication type:
- Article
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 77, doi. 10.1007/s13300-022-01328-7
- By:
- Publication type:
- Article
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 509, doi. 10.1007/s13300-020-00982-z
- By:
- Publication type:
- Article
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 10, p. 2283, doi. 10.1007/s13300-020-00902-1
- By:
- Publication type:
- Article
110-LB: Efficacy, Safety, and Appropriateness of iGlarLixi, a Fixed-Ratio Combination (FRC) in Type 2 Diabetes (T2D) in Real-World Settings: Results from the ENSURE Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-110-LB
- By:
- Publication type:
- Article
109-LB: Comparative Effectiveness of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (iDeg-100) in Insulin-Naïve Type 2 Diabetes Adults: RESTORE-2 Real-World Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-109-LB
- By:
- Publication type:
- Article